Plus Therapeutics, Inc. (PSTV) insider trading.
In Q3 2026, insiders at Plus Therapeutics, Inc. reported 11 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 11
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 7
- Last filed
- 2026-07-01
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Hedrick Marc H | Director, Officer · Chief Executive Officer | 3 | 0 | 0 |
| Sims Andrew John Hugh MacIntyre | Officer · Chief Financial Officer | 3 | 0 | 0 |
| Clowes Howard | Director | 1 | 0 | 0 |
| van Es-Johansson An | Director | 1 | 0 | 0 |
| Guse Kyle | Director | 1 | 0 | 0 |
| Hawkins Richard J | Director | 1 | 0 | 0 |
| Andrews Ronald Asbury | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | Clowes Howard | M (A) | 922 | $0 | 1,981 | Form 4 |
| 2026-07-01 | Hedrick Marc H | M (A) | 8,066 | $0 | 42,497 | Form 4 |
| 2026-07-01 | Hedrick Marc H | M (A) | 6,387 | $0 | 34,431 | Form 4 |
| 2026-07-01 | Hedrick Marc H | M (A) | 1,986 | $0 | 44,483 | Form 4 |
| 2026-07-01 | van Es-Johansson An | M (A) | 922 | $0 | 922 | Form 4 |
| 2026-07-01 | Guse Kyle | M (A) | 922 | $0 | 922 | Form 4 |
| 2026-07-01 | Hawkins Richard J | M (A) | 922 | $0 | 1,529 | Form 4 |
| 2026-07-01 | Sims Andrew John Hugh MacIntyre | M (A) | 1,165 | $0 | 9,654 | Form 4 |
| 2026-07-01 | Sims Andrew John Hugh MacIntyre | M (A) | 287 | $0 | 9,941 | Form 4 |
| 2026-07-01 | Sims Andrew John Hugh MacIntyre | M (A) | 1,533 | $0 | 8,489 | Form 4 |
| 2026-07-01 | Andrews Ronald Asbury | M (A) | 922 | $0 | 922 | Form 4 |
Transaction codes in this quarter
Get PSTV insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1095981&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · Plus Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Plus Therapeutics, Inc. (PSTV)?
In Q3 2026, insiders at Plus Therapeutics, Inc. reported 11 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Plus Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/pstv.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.